These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 31905339)

  • 41. [Drug-induced immune hemolytic anemia caused by cefmetazole].
    Shioji N; Mizutani M; Okayama M; Katayama H; Ooya E; Sekine T; Masuya M
    Rinsho Ketsueki; 2018; 59(7):884-888. PubMed ID: 30078798
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007.
    Garratty G; Arndt PA
    Immunohematology; 2014; 30(2):66-79. PubMed ID: 25247621
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug-induced immune hemolytic anemia.
    Garratty G
    Clin Adv Hematol Oncol; 2010 Feb; 8(2):98-101. PubMed ID: 20386530
    [No Abstract]   [Full Text] [Related]  

  • 44. Albuterol-induced myocardial ischemia in sickle cell anemia after hemolysis from ceftriaxone administration.
    Corso M; Ravindranath TM
    Pediatr Emerg Care; 2005 Feb; 21(2):99-101. PubMed ID: 15699818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unusual serological findings associated with ceftriaxone-induced immune hemolytic anemia in a child with disseminated low-grade glioma.
    Pecker LH; Timsar A; Pary PP; Denomme GA; Criss VR; Luban NL; Hwang EI; Wong EC
    Pediatr Blood Cancer; 2016 Oct; 63(10):1852-5. PubMed ID: 27304608
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Severe drug-induced immune hemolytic anemia due to cefmetazole: A case report.
    Fukuda M; Nabeta M; Oya S; Takasu O
    Int J Clin Pharmacol Ther; 2022 Jan; 60(1):52-56. PubMed ID: 34672255
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug-induced immune hemolytic anemia: detection of new signals and risk assessment in a nationwide cohort study.
    Maquet J; Lafaurie M; Michel M; Lapeyre-Mestre M; Moulis G
    Blood Adv; 2024 Feb; 8(3):817-826. PubMed ID: 37782770
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug-induced immune hemolytic anemia: the last 30 years of changes.
    Arndt PA
    Immunohematology; 2014; 30(2):44-54. PubMed ID: 25247622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature.
    Seltsam A; Salama A
    Intensive Care Med; 2000 Sep; 26(9):1390-4. PubMed ID: 11089773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of piperacillin-induced hemolytic anemia in patients with cystic fibrosis and antipseudomonal treatment: a prospective observational study.
    Roehmel J; Specht P; Staab D; Schwarz C; Salama A; Mayer B
    Transfusion; 2019 Dec; 59(12):3746-3754. PubMed ID: 31724753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bendamustine-induced immune hemolytic anemia in a chronic lymphocytic leukemia patient: A case report and review of the literature.
    Haddad H; Mohammad F; Dai Q
    Hematol Oncol Stem Cell Ther; 2014 Dec; 7(4):162-4. PubMed ID: 24785506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibiotic hypersensitivity in CF: drug-induced life-threatening hemolytic anemia in a pediatric patient.
    Chavez A; Mian A; Scurlock AM; Blackall D; Com G
    J Cyst Fibros; 2010 Dec; 9(6):433-8. PubMed ID: 20833594
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute and fatal cephalosporin-induced autoimmune haemolytic anaemia.
    Boilève A; Gavaud A; Grignano E; Franck N; Carlotti A; Mira JP; Bouscary D; Jozwiak M
    Br J Clin Pharmacol; 2021 Apr; 87(4):2152-2156. PubMed ID: 33075171
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autoimmune hemolytic anemia associated with trimethoprim-sulfamethoxazole use.
    Frieder J; Mouabbi JA; Zein R; Hadid T
    Am J Health Syst Pharm; 2017 Jun; 74(12):894-897. PubMed ID: 28596226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cefazolin-induced hemolytic anemia: a case report and systematic review of literature.
    Mause E; Selim M; Velagapudi M
    Eur J Med Res; 2021 Nov; 26(1):133. PubMed ID: 34819145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fatal ceftriaxone-induced hemolysis in a child with acquired immunodeficiency syndrome.
    Borgna-Pignatti C; Bezzi TM; Reverberi R
    Pediatr Infect Dis J; 1995 Dec; 14(12):1116-7. PubMed ID: 8745031
    [No Abstract]   [Full Text] [Related]  

  • 57. Severe immune haemolytic anaemia due to ceftriaxone in a patient with congenital nephrotic syndrome.
    Reis Boto ML; Sandes AR; Brites A; Silva S; Stone R; Almeida M
    Acta Paediatr; 2011 Oct; 100(10):e191-3. PubMed ID: 21450013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Severe hemolysis induced by ceftriaxone in a child with sickle-cell anemia.
    Viner Y; Hashkes PJ; Yakubova R; Segal-Kupershmit D; Luder AS
    Pediatr Infect Dis J; 2000 Jan; 19(1):83-5. PubMed ID: 10643859
    [No Abstract]   [Full Text] [Related]  

  • 59. Ceftriaxone induced immune hemolytic anemia: detection of drug-dependent antibody by ex-vivo antigen in urine.
    Kim S; Song KS; Kim HO; Lee HM
    Yonsei Med J; 2002 Jun; 43(3):391-4. PubMed ID: 12089751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ceftriaxone-induced drug reaction mimicking acute splenic sequestration crisis in a child with hemoglobin SC disease.
    Van Buren NL; Gorlin JB; Reed RC; Gottschall JL; Nelson SC
    Transfusion; 2018 Apr; 58(4):879-883. PubMed ID: 29473172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.